tetano
Editor, Senior Moderator
Heliyon. 2016 May 6;2(5):e00098. doi: 10.1016/j.heliyon.2016.e00098. eCollection 2016.
[h=1]Gene signatures related to HAI response following influenza A/H1N1 vaccine in older individuals.[/h] Ovsyannikova IG[SUP]1[/SUP], Oberg AL[SUP]2[/SUP], Kennedy RB[SUP]1[/SUP], Zimmermann MT[SUP]2[/SUP], Haralambieva IH[SUP]1[/SUP], Goergen KM[SUP]2[/SUP], Grill DE[SUP]2[/SUP], Poland GA[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] To assess gene signatures related to humoral response among healthy older subjects following seasonal influenza vaccination, we studied 94 healthy adults (50-74 years old) who received one documented dose of licensed trivalent influenza vaccine containing the A/California/7/2009 (H1N1)-like virus strain. Influenza-specific antibody (HAI) titer in serum samples and next-generation sequencing on PBMCs were performed using blood samples collected prior to (Day 0) and at two timepoints after (Days 3 and 28) vaccination. We identified a number of uncharacterized genes (ZNF300, NUP1333, KLK1 and others) and confirmed previous studies demonstrating specific genes/genesets that are important mediators of host immune responses and that displayed associations with antibody response to influenza A/H1N1 vaccine. These included interferon-regulatory transcription factors (IRF1/IRF2/IRF6/IRF7/IRF9), chemokine/chemokine receptors (CCR5/CCR9/CCL5), cytokine/cytokine receptors (IFNG/IL10RA/TNFRSF1A), protein kinases (MAP2K4/MAPK3), growth factor receptor (TGFBR1). The identification of gene signatures associated with antibody response represents an early stage in the science for which further research is needed. Such research may assist in the design of better vaccines to facilitate improved defenses against new influenza virus strains, as well as better understanding the genetic drivers of immune responses.
[h=4]KEYWORDS:[/h] Genetics; Immunology
PMID: 27441275 DOI: 10.1016/j.heliyon.2016.e00098
[PubMed]
[h=1]Gene signatures related to HAI response following influenza A/H1N1 vaccine in older individuals.[/h] Ovsyannikova IG[SUP]1[/SUP], Oberg AL[SUP]2[/SUP], Kennedy RB[SUP]1[/SUP], Zimmermann MT[SUP]2[/SUP], Haralambieva IH[SUP]1[/SUP], Goergen KM[SUP]2[/SUP], Grill DE[SUP]2[/SUP], Poland GA[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] To assess gene signatures related to humoral response among healthy older subjects following seasonal influenza vaccination, we studied 94 healthy adults (50-74 years old) who received one documented dose of licensed trivalent influenza vaccine containing the A/California/7/2009 (H1N1)-like virus strain. Influenza-specific antibody (HAI) titer in serum samples and next-generation sequencing on PBMCs were performed using blood samples collected prior to (Day 0) and at two timepoints after (Days 3 and 28) vaccination. We identified a number of uncharacterized genes (ZNF300, NUP1333, KLK1 and others) and confirmed previous studies demonstrating specific genes/genesets that are important mediators of host immune responses and that displayed associations with antibody response to influenza A/H1N1 vaccine. These included interferon-regulatory transcription factors (IRF1/IRF2/IRF6/IRF7/IRF9), chemokine/chemokine receptors (CCR5/CCR9/CCL5), cytokine/cytokine receptors (IFNG/IL10RA/TNFRSF1A), protein kinases (MAP2K4/MAPK3), growth factor receptor (TGFBR1). The identification of gene signatures associated with antibody response represents an early stage in the science for which further research is needed. Such research may assist in the design of better vaccines to facilitate improved defenses against new influenza virus strains, as well as better understanding the genetic drivers of immune responses.
[h=4]KEYWORDS:[/h] Genetics; Immunology
PMID: 27441275 DOI: 10.1016/j.heliyon.2016.e00098
[PubMed]